Shinzaki S, Matsuoka K, Tanaka H, Takeshima F, et al. Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study. J Gastroenterol 2021 May 3. pii: 10.1007/s00535-021-01793.
PMID: 33942166